Podcast: Play in new window | Download
Subscribe: RSS
Dr. Bonni Goldstein returns to the podcast to discuss examples where cannabis may be a safer and more effective therapeutic than traditional pharmaceutical drugs.
Bonni is one of the country’s most respected and experienced medical cannabis physicians, having treated thousands of patients with medical cannabis. She is the owner and medical director of Canna-Centers Wellness & Education. She is Clinical Advisor to Cannformatics. And she is the author of the book titled “Cannabis is Medicine: How Medical Cannabis and CBD Are Healing Everything from Anxiety to Chronic Pain”.
Topics discussed include:
- Substituting cannabis for NSAIDS
- Substituting cannabis for anti-anxiety and antidepressant medication
- Substituting cannabis for opioids
- Substituting cannabis for sleeping pills
- Substituting cannabis for alcohol
- Tips for dosing
- Formulation recommendations
- Results from a new study evaluating cannabis to treat Autism
Thank You to This Episode’s Sponsor: Cannformatics
Cannformatics is an early-stage biotechnology startup focused on developing Cannabis-Responsive™ biomarkers as a universal tool for measuring cannabis’ and CBD’s physiological impact. Cannformatics provides health care professionals, patients and medical cannabis producer processors with the tools and technology needed for developing evidence-based medical cannabis and CBD treatments and products. Cannformatics mission is to develop technologies that enable predictable and repeatable science-based medical cannabis outcomes that improve health and quality of life.
To learn more visit cannformatics.com
Additional Resources
- Cannabis is Medicine [Book]
- Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly [Survey]
- The Impact of Medical Cannabis on Intermittent and Chronic Opioid Users with Back Pain: How Cannabis Diminished Prescription Opioid Usage
- NSAIDs and gastrointestinal complications: new clinical challenges
- Cardiovascular effects and safety of (non-aspirin) NSAIDs
- Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder
- CannMed Archive
- CannMed Community Board [Facebook Group]
- Healthcare Provider Medical Cannabis Research Study